Catalyst Pharmaceutical Partners , Nasdaq: CPRX
A pharmaceutical company developing prescription drugs to treat addiction.
Industry: Health Care
First Day Return: +1.7%
Industry: Health Care
CPRX
A pharmaceutical company developing prescription drugs to treat addiction.
| IPO Data | |
|---|---|
| IPO File Date | 07/25/2006 |
| Offer Price | $6.00 |
| Price Range $11.00 - $13.00 | |
| Offer Shares (mm) | 3.4 |
| Deal Size ($mm) | $20 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 11/07/2006 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $20 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Coral Gables, FL, United States |
| Founded | 2002 |
| Employees at IPO | 4 |
| Website www.catalystpharma.com | |
IPO News for Catalyst Pharmaceutical Partners
Catalyst Pharmaceutical Partners (CPRX) Performance
